Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori treatment in drug-resistant idiopathic generalized epilepsy
NCT05297695Phase 3Completed
- Sponsor
- Sohag University
- Start
- Apr 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of esomeprazole, amoxicillin and clarithromycin in Helicobacter pylori infection, sponsored by Sohag University. Primary endpoint: Seizure improvement at 10 weeks. Started Apr 2022; status: completed.
02
Drugs
esomeprazoleamoxicillinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05297695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05297695.